Syndax Pharmaceuticals (SNDX) Stock: Buy, Sell, or Hold?
$9.54
-0.05 (-0.52%)
▼
5d:
+1.81%
30d:
-29.49%
90d:
-51.92%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 02, 2026
0d
Protect SNDX Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
58/100
Position
OVERSOLD
30-Day Fair Range
$10.81 – $15.88
Position: OVERSOLD
Forward P/E & Valuation
-12.2x
CHEAP
vs 126.3x historical avg
Wall Street Target
$35.45
+271.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.15 / $14.69
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: SNDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $9.54, which is considered oversold relative to its 30-day fair value range of $10.81 to $15.88. From a valuation perspective, the stock is trading at a discount (Forward PE: -12.2) compared to its historical average (126.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNDX is in a strong downtrend. Immediate support is located at $9.14, while resistance sits at $14.69.
Market Sentiment: SNDX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $35.45 (+271.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNDX is in a strong downtrend. Immediate support is located at $9.14, while resistance sits at $14.69.
Market Sentiment: SNDX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $35.45 (+271.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.81 -
$15.88
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
Trading Range & Key Levels
30-Day Trading Range
$10.81 -
$15.88
Current vs Trading Range
OVERSOLD
Support Level
$9.15
Resistance Level
$14.69
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding SNDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 271.6% below Wall St target ($35.45)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-12.19
Wall Street Target
$35.45
(+271.6%)
Revenue Growth (YoY)
81.6%
Profit Margin
-72.3%
PE vs Historical
-12.2 vs 126.3
CHEAP
Share SNDX Analysis
Share this live SNDX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SNDX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Syndax Pharmaceuticals announced the hiring of a new CFO and the inducement grant given to him in connection to his employment, with shares vesting over a four-year period.
Key Retail Themes:
New CFO hire
Inducement grant
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:49 AM ET
Data refreshes hourly during market hours. Next update: 5:49 AM
Data refreshes hourly during market hours. Next update: 5:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Advanced SNDX Option Strategies
Professional options setups generated by AI based on today's SNDX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SNDX Research Pages
